Chris Preti

Chris Preti serves as the Chief Executive Officer and President of Jubilant HollisterStier Contract Manufacturing & Services since January 2023, overseeing an integrated contract manufacturing operation specializing in sterile injectables and other pharmaceutical products. Prior to this role, Chris held the position of President at HollisterStier Allergy from January 2018 to January 2023, contributing to the global expansion of allergy treatments. Chris's extensive career at GSK included multiple leadership roles, such as Vice President of COPD Marketing and Vice President of Operations, with significant responsibilities across various marketing and sales functions. Academically, Chris holds an MBA in International Business from the University of South Carolina Darla Moore School of Business, a Master of Science in Chemistry, and a Bachelor of Science in Chemistry from Furman University, along with executive leadership training from The Wharton School.